CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Alogliptin plus metformin
Brand Name: Kazano
Manufacturer: Takeda Canada Inc.
Indications: Diabetes mellitus (Type 2)
Submission Type: New
Project Status: Complete
Date Recommendation Issued: January 15, 2015
Recommendation Type: Do not list
